Mercado MÁ

Idioma: Español
Referencias bibliográficas: 18
Paginas: 5-8
Archivo PDF: 35.97 Kb.

FRAGMENTO

La prevención del carcinoma hepatocelular es factible, dado que la mayoría de los tumores se originan sobre sustratos patológicos reconocidos en el hígado. La prevención tiene diferencias en áreas geográficas, no sólo por sus características epidemiológicas, sino incluso económicas. Colombo ha definido dos tipos de estrategias preventivas: 1) aparición de la lesión (primaria), 2) disminución de recurrencia postoperatoria (secundaria).

REFERENCIAS (EN ESTE ARTÍCULO)

1. Colombo M. Surveillance and prevention of hepatocellular carcinoma. En Falk Symposium 160. Pathogenesis and clinical practice in gastroenterology. 2008 Springer annual Falk Foundation. 239-251

2. Sangiovanni A, Del Ninno E, Fasani P, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected Turing surveillance. Gastroenterology 2004; 126: 1005-1014.

3. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic Nodules. Semin Diver Dir 2005; 25: 133-42.

4. Forner A, Villana R, Ayusco C, Bianchi L, et al. Diagnosis of hepatic nodules 20 Mn or smaller in cirrhosis: prospective validation of the Non invasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008; 47: 97-104.

5. Sala M, Forner A, Varela M, Bruix J. Prognostic prediction in patients with hepatocellular carcinoma. Jemin Liver Dis 2005; 25: 171-80.

6. Geissler M, Kramer S. Hepatozelluläres karzinom: diagnosticscher algorithmus. Viszeral Medizin 2009; 25: 79-83.

7. Levy I, Greig PD, Gallinger S, Langer B, Sherman M. Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg 2004; 234: 208-209.

8. Simons JP, Ng S, C Hill Js, Shah SA, Zhou Z. A simple risk score predicts inpatient mortality after liver resection for hepatocellular carcinoma. HPB. 2009; 11: 3.

9. Nathan H, Mentha G, Marques HP, Capussoh L, Majno P. Comparative performance of staging systems for early hepatocellular carcinoma. HPB 2009; 11: 16.

10. Aloia TA, Fahy BN Fischer CP, Jones SL, Ductini A, Galati A. Predicting poor outcome following hepatectomy: analysis of 2,313 hepatectomies in the NSQIP database HPB. 2009; 11: 26.

11. Teh SH, Hammill C, Wong L, et al. Validation for the Meld based objective scoring system. HPB 2009; 11: 26

12. Roayaie D, Bassi D, Hiotis S, Lebow D, Schwartz M. Second hepatic resection for recurrent hepatocellular carcinoma. HPB 2009; 11: 1.

13. Shumaccher A, Powell J, Buczkowski A, Sundamore C, Multimodal therapy for treatment of hepatocellular carcinoma : A ten year survival analysis. HPB 2009; 11: 25.

14. Facciuto M, Pandey M, Rochon C, Rodríguez VM, Wolf DC. Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention to treat analysis in patients within and outside Milan criteria. HPB 2009; 11: 34.

15. Belghiti J, Herrero A, Pulitano C, Fargen O, Sauvante A. Partial liver resection for HCC in patients with good liver function can challenge liver transplantation. HPB 2009; 11: 37.

16. Nathan H, Schulick R D, Choti MA, Pawlite TM. National trends in patient treatment and procedure related mortality for hepatocellular carcinoma. HPB 2009; 11: 40.

17. Ehrenwald E, Sieloff T, Mackenzie S, Kasari K. Transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) using doxorubicin eluting microspheres (DEB). Initial results. HPB 2009; 11: 49.

18. Mazaferro V, Regalic E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinoma a life expectancy and cost–effectiveness perspective. Hepatology 2001; 33: 1073-9.